+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 47 Pages
  • November 2023
  • Region: United States
  • GlobalData
  • ID: 4377318
University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is a leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson offers cancer treatment, cancer research, education, and research-based prevention of both common and rare cancers in adult and pediatric patients. Its major departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers graduate, undergraduate, and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; among others. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Oct 04,2023: CTMC Partners With Scaleready to Automate, Close, and Scale for Greater Patient Accessibility
Jul 26,2023: Nexo Launches Chemical Biology Platform to Pursue Previously Intractable Targets
Jul 13,2023: Best Workplaces for Disability Inclusion: 15 Health Systems
Jun 12,2023: Myriad Genetics Announces Research Collaboration to Use Minimal Residual Disease Testing Platform

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • University of Texas MD Anderson Cancer Center - Key Facts
  • University of Texas MD Anderson Cancer Center - Key Employees
  • University of Texas MD Anderson Cancer Center - Key Employee Biographies
  • University of Texas MD Anderson Cancer Center - Major Products and Services
  • University of Texas MD Anderson Cancer Center - History
  • University of Texas MD Anderson Cancer Center - Company Statement
  • University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • University of Texas MD Anderson Cancer Center - Business Description
  • Business Segment: Auxiliary income
  • Performance
  • Business Segment: Investment and Other Non-operating Income
  • Performance
  • Business Segment: Net Patient Revenue
  • Performance
  • Business Segment: Other Income
  • Performance
  • Business Segment: Restricted Grants and Contracts, Philanthropy
  • Performance
  • Business Segment: State-appropriated General Revenue
  • Performance
  • R&D Overview
  • University of Texas MD Anderson Cancer Center - Corporate Strategy
  • University of Texas MD Anderson Cancer Center - SWOT Analysis
  • SWOT Analysis - Overview
  • University of Texas MD Anderson Cancer Center - Strengths
  • University of Texas MD Anderson Cancer Center - Weaknesses
  • University of Texas MD Anderson Cancer Center - Opportunities
  • University of Texas MD Anderson Cancer Center - Threats
  • University of Texas MD Anderson Cancer Center - Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary
Section 3 - Company’s Recent Developments
  • Oct 04, 2023: CTMC Partners With Scaleready to Automate, Close, and Scale for Greater Patient Accessibility
  • Jul 26, 2023: Nexo Launches Chemical Biology Platform to Pursue Previously Intractable Targets
  • Jul 13, 2023: Best Workplaces for Disability Inclusion: 15 Health Systems
  • Jun 12, 2023: Myriad Genetics Announces Research Collaboration to Use Minimal Residual Disease Testing Platform
  • Apr 06, 2023: Metastasis-directed radiation therapy plus hormone therapy improves progression-free survival for men with advanced prostate cancer
  • Mar 08, 2023: MD Anderson research highlights for March 8, 2023
  • Feb 16, 2023: MD Anderson and Xilis partner to expedite new cancer therapies development
  • Feb 15, 2023: MD Anderson receives nearly $19.4 million in CPRIT funding
  • Feb 14, 2023: KKR-backed Replay and MD Anderson form new product company Syena to pioneer first-in-class TCR-NK cell therapy
  • Feb 13, 2023: Lung cancer study finds new target for treatment resistance after EGFR inhibitors
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • University of Texas MD Anderson Cancer Center, Key Facts
  • University of Texas MD Anderson Cancer Center, Key Employees
  • University of Texas MD Anderson Cancer Center, Key Employee Biographies
  • University of Texas MD Anderson Cancer Center, Major Products and Services
  • University of Texas MD Anderson Cancer Center, History
  • University of Texas MD Anderson Cancer Center, Other Locations
  • University of Texas MD Anderson Cancer Center, Subsidiaries
  • University of Texas MD Anderson Cancer Center, Joint Venture
  • University of Texas MD Anderson Cancer Center, Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • TIRR Memorial Hermann
  • Texas Children's Cancer Center
  • Houston Methodist Hospital
  • Cancer Therapy and Research Center
  • Baylor St Luke's Medical Center
  • TIRR Memorial Hermann
  • Texas Children's Cancer Center
  • Houston Methodist Hospital
  • Cancer Therapy and Research Center
  • Baylor St Luke's Medical Center